Navigation Links
MicroDose and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDose's Electronic Dry Powder Inhaler
Date:1/6/2009

Dose indicated that "the combination of Nexus 6 Technology and MicroDose's dry powder inhaler will insure a continuous flow of 'real time' clinical information which will benefit physicians, patients and pharmaceutical companies."

David Evans, CEO of Nexus6 said "this partnership between Nexus6 and MicroDose will enable the drug delivery marketplace to access leading edge data collection and transmission capabilities, thereby increasing pharmaceutical adherence, improving patient well-being and reducing overall health care costs."

About the MicroDose DPI

The MicroDose DPI is among a number of key proprietary drug delivery platforms developed by MicroDose. By employing piezo electronics, the MicroDose DPI has the potential to deliver enhanced performance versus other inhalers, for efficient and reproducible delivery independent of patient coordination, inhalation rate and posture. Microdose believes that the flexibility of the inhaler makes it a true platform technology, able to support a broad pipeline of products across the spectrum of patient populations and therapeutic categories.

About MicroDose Technologies

MicroDose Technologies, Inc., based in Monmouth Junction, New Jersey, is a leading privately-held drug delivery and specialty pharmaceuticals company, developing advanced pulmonary, fixed-dose-combination oral dosage, and other technologies and products for the pharmaceutical and biotechnology industries.

MicroDose's partnered programs include; multi-product development and licensing agreements with Merck and Co. and Novartis, the development of an inhaled insulin product through MicroDose's QDose joint venture, and an inhaler for the systemic delivery of a nerve agent antidote for the US Department of Defense, in collaboration with the University of Pittsburgh. MicroDose is also conducting internal development programs for products employing its
'/>"/>

SOURCE MicroDose Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Horizon Therapeutics Announces Senior Management Appointments
2. BioSpecifics Technologies Corp. Announces Listing on NASDAQ Global Market
3. Star Scientific Announces Successful Completion of Product Satisfaction Study - Results Show Potential for Development and Manufacturing of New Pharmaceutical Product for Smoking and Smokeless Tobacco Cessation
4. ADVENTRX Announces Further Cost-Cutting Measures
5. Health Robotics Announces Results of the European Union-Sponsored SafeChemo Project
6. West Penn Allegheny Health System Announces Recruitment of Leading Burn Specialists
7. Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
8. Medical Machines Online Announces Release of a Brand New Philips HeartStart AED Defibrillator
9. Health Robotics Announces Partnership in the Peoples Republic of China With The Devon International Group
10. Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso
11. Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Oven Industries Inc. announces a new ... 5R6-900 benchtop controller has many outstanding user-friendly benefits. Contained ... into the wall as a self-contained temperature control system, ... makes the device unique, as well as highly convenient ... can also be used universally, which allows the user ...
(Date:5/20/2013)... 2013  Dr. Gerald Zon , ... recently launched a new blog in conjunction with TriLink ... ), focuses on what,s trending in the field of ... leaders, discussions of research presented at conferences and meetings, ... Dr. Zon (PhD Princeton University 1971) developed automated synthesis ...
(Date:5/20/2013)... , May 20, 2013 Cempra, Inc. ... developing differentiated antibiotics to meet critical medical needs ... that it presented data at the American Thoracic ... Philadelphia demonstrating the antibacterial and enhanced ... prior Phase 2 clinical trial in outpatients with ...
(Date:5/20/2013)... May 20, 2013 Researchers from the ... connection between lower back pain, and the acne causing P.acnes ... the system the bacteria seek out oxygen deprived location to ... the spinal column, P.acnes has the ability to live in ... Fernando Perez, a spokesman for “ The best acne treatment ...
Breaking Biology Technology:New Laboratory Temperature Controller by Oven Industries 2Dr. Gerald 'Jerry' Zon Launches New Blog for TriLink BioTechnologies 2Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2Adult Acne Treatment, Probiotic Action Shares New Insight How Treating Acne May Help Reduce Body Pain 2
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ... Executive Officer of BioMarin, will host a ... 28, at 5:00 p.m. ET to discuss ... Dial-in Number:  888.396.2386International Dial-in Number:  617.847.8712Participant Code: ...
... 28, 2011 The Japanese nuclear crisis has caused ... shortages not only in Japan, but as far away ... potassium iodide does not provide generalized radiation protection because ... being bombarded with orders as the radiation hysteria mounts. ...
... CAMBRIDGE, Mass. -- In recent years, many airplane manufacturers ... which consist of high-strength fibers, such as carbon or ... materials are stronger and more lightweight than aluminum, but ... because their surfaces usually don,t reveal underlying problems. ...
Cached Biology Technology:BioMarin to Host First Quarter 2011 Financial Results Conference Call and Webcast on Thursday, April 28 at 5:00 p.m. ET 2Shortages of Potassium Iodide as Radiation Panic Drives Demand 2MIT engineers devise new way to inspect materials used in airplanes 2
(Date:5/19/2013)... Davis have engineered a strain of photosynthetic cyanobacteria to ... their findings today at the 113th General Meeting of ... we used synthetic biology approaches to probe and rewire ... for growth) cyanobacterial metabolism for the ability to grow ... on the study. He is part of Shota ...
(Date:5/18/2013)... 2013) Research presented at Digestive Disease Week ... through diet and lifestyle. , Individuals suffering ... muscle strength, fatigue and poor quality of life. ... in remission. A randomized, double blind, placebo-controlled study ... supplementation corresponded to significant relief of these symptoms. ...
(Date:5/17/2013)... By day, insects provide the white noise of the South, ... typical year, the Southern air hangs heavy from the humidity ... to more than 140 species of frogs, toads and salamanders, ... If the ponds and swamps are the auditorium for their ... Research and Monitoring Initiative, or ARMI, have front-row seats. ...
Breaking Biology News(10 mins):Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4
... July 28, 2011 A paper published today in ... novel, proprietary monoclonal antibody (FI6) discovered in a collaboration ... Biomedicine ("IRB") and the UK Medical Research Council (MRC). ... 16 hemagglutinin subtypes of influenza A and represents an ...
... Escape responses are some of the most studied ... brain processes sensory information. The ability to evade predators ... selection. Animals explore their environment to find food, find ... escape responses to avoid predators, thereby increasing their chances ...
... approach which focuses on understanding the complex relationships ... of an aggressive form of breast cancer, researchers for ... in the blood that change in abundance long before ... Christopher Kemp, Ph.D., and Samir Hanash, M.D., Ph.D., members ...
Cached Biology News:Humabs discovers the first antibody to neutralize both group 1 and group 2 influenza A viruses 2Elusive prey 2Using a 'systems biology' approach to look under the hood of an aggressive form of breast cancer 2
RayBio Human Angiogenesis Antibody Array 2.1 (8 array membranes) with Accessory, detects 23 angiogenic factors (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
... Cryo/CryoPlus Inventory Racks for cryogenic ... with cardboard or stainless steel ... 5ml cryo vials. Vapor ... available. Platform risers to ...
Rat CINC-2 alpha/beta Affinity Purified Polyclonal Ab...
Mouse TREM-2 Affinity Purified Polyclonal Ab...
Biology Products: